Zimmer Biomet’s fourth quarter and full year sales increased, according to financial results posted Feb. 10.
Seven things to know:
1. Full year sales reached $8.2 billion, a 7.2% increase year over year.
2. Knee sales in 2025 were $3.3 billion, and hip sales were $2.1 billion. Both saw 4.7% year over year increases.
3. Sports Medicine, extremities, trauma, craniomaxillofacial and thoracic sales in 2025 was $2.15 billion, a 15.2% increase year over year.
4. Fourth quarter sales grew 10.9% year over year with $2.2 billion.
5. Net earnings for the fourth quarter were $139.3 million and $705.1 million for the full year.
6. The company’s 2026 guidance expects a 2.5% to 4.5% increase in full-year revenue.
7. “We closed the year strong with meaningful revenue acceleration and two consecutive quarters of mid-single digit organic growth fueled by our new product innovation cycle,” CEO Ivan Tornos, said in a news release. “As we enter 2026, we are excited about our transition to a predominantly direct and specialized sales organization in the U.S. While this bold action tempers our 2026 sales guidance, we are confident that it will drive durable long-term growth and solidify our position as the undisputed market leader.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.